Viva Biotech Investor
Preclinical research and development of innovative drugsViva Biotech Holdings engages in preclinical research and development of innovative drugs. The firm provides structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide for their preclinical stage innovative drug development.Viva Biotech | Company Overview & News - Forbeswww.forbes.com/viva-biotech/Was this helpful?
Founded Date:
2008-01-01
Funding Status:
Post-IPO Equity
Total Funding:
247464000
Employee Number:
101-250
Headquarters:
Shanghai, Shanghai, China
Last Funding Date:
2023-06-13
Investors Number:
9
Last Funding Type:
Post-IPO Equity
Estimated Revenue:
$10M to $50M
Number Of Exists:
2
Industry:
Imaging